换一批Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells.
第一作者：
Laurence,Catley
第一单位：
Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA.
作者：
医学主题词
硼酸化物(Boronic Acids);药物协同作用(Drug Synergism);组蛋白脱乙酰基酶抑制剂(Histone Deacetylase Inhibitors);人类(Humans);水解酶类(Hydrolases);羟肟酸类(Hydroxamic Acids);吲哚类(Indoles);多发性骨髓瘤(Multiple Myeloma);蛋白酶抑制药(Protease Inhibitors);吡嗪类(Pyrazines);微管蛋白(Tubulin);微管蛋白调节因子(Tubulin Modulators);肿瘤细胞, 培养的(Tumor Cells, Cultured)
DOI
10.1182/blood-2006-04-016055
PMID
16728695
发布时间
2024-05-10
- 浏览149
Blood
3441-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
